Alembic Pharmaceuticals on Friday said it has received approval from the US health regulator to market a generic medication for the prevention of heart attack and stroke. The company has received ...

Managing complex medication schedules could soon become as simple as taking a single capsule each day. Engineers at the ...

Helen Knight, director of medicines evaluation at Nice, said: “We’re pleased to recommend linzagolix as a new treatment ...

The FDA has approved a monoclonal antibody to treat individuals aged 12 years and older with generalized myasthenia gravis ...

Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Niacin Extended-Release Tablets USP, 500 mg, 750 mg, and 1,000 mg (Niaspan ...

The Directorate General of Foreign Trade (DGFT), under the Ministry of Commerce and Industry, has issued a public notice dated April 24, 2025, to introduce a new Standard Input Output Norm (SION).

Pharma major Lupin Ltd on Thursday said it has received approval from the US health regulator for its generic version of ...

UTs did not submit NSQ data with Centre in March: Gireesh Babu, New Delhi Wednesday, April 23, 2025, 08:00 Hrs [IST] The number of states failing to submit the mon ...

Summary: OmniVision has finally boarded the bandwagon of 1-inch image sensor manufacturers. It has introduced the OV50X, a 50MP sensor with a 1.6-micron pixel in a 1-inch format. The OV50X is the ...

Life-brand melatonin tablets are being recalled because they have the wrong dosing instructions on the label. The recall, published by Health Canada, did not specify what the incorrect ...

On Tuesday, Health Canada issued alerts for one lot of Laboratoire Riva Inc.’s acetaminophen 500 milligram caplet and six lots of Life Brand’s Timed Release Melatonin 10 mg tablet. Health ...

The 10th-generation Apple iPad, the latest model of Apple’s entry-level tablet, is highlighted in our list of the best iPads as the top mid-range iPad because of its modern design, the switch to ...